logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

20 New IPOs for Week of July 28

By  +Follow July 28, 2014 1:53PM
Share:
Tickers Mentioned:

Full IPO calendar & reports HERE.  In order of largest IPO first:

 

(1) Based in Stamford, CT, Synchrony Financial (SYF) scheduled a $3.06 billion IPO on the NYSE with a market capitalization of $20.3 billion at a price range midpoint of $24 for Thursday, July 31, 2014.

SYF is one of the premier consumer financial services companies in the United States. It's the old GE Capital.

 

(2) Based in Somerset, NJ, Catalent (CTLT) scheduled a $871 million IPO on the NYSE with a market capitalization of $2.4 billion at a price range midpoint of $20.50 for Thursday, July 31, 2014.

CTLT is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

 

(3) Based in Jerusalem, Israel, Mobileye N.V. (MBLY) scheduled a $500 million IPO on the NYSE with a market capitalization of $3.8 billion at a price range midpoint of $18 for Friday, August 1, 2014.

MBLY is the global leader in the design and development of software and related technologies for camera-based Advanced Driver Assistance Systems (“ADAS”).

 

(4) Based in London, United Kingdom, VTTI Energy Partners LP  (VTTI) scheduled a $350 million IPO on the NYSE, with a market capitalization of $402 million at a price range midpoint of $20 for Friday, August 1, 2014.

VTTI is a fee-based, growth-oriented limited partnership formed in April 2014 by VTTI, one of the world’s largest independent energy terminaling businesses, to own, operate, develop and acquire refined petroleum product and crude oil terminaling and related energy infrastructure assets on a global scale.

 

(5) Based in Aberdeen, United Kingdom,Transocean Partners (RIGP) scheduled a $350 million IPO on the NYSE with a market capitalization of $827 million at a price range midpoint of $20 for Thursday, July 31, 2014.

RIGP is a growth-oriented limited liability company recently formed by Transocean,one of the world’s largest offshore drilling contractors, to own, operate and acquire modern, technologically advanced offshore drilling rigs.

 

(6) Based in Houston, TX, Westlake Chemical Partners LP (WLKP) scheduled a $225 million IPO on the NYSE with a market capitalization of $508 milliion at a price range midpoint of $20 for Wednesday, July 30, 2014.

WLKP is a Delaware limited partnership recently formed by Westlake to operate, acquire and develop ethylene production facilities and related assets.

 

(7) Based in Weston, FL, FCB Financial Holdings (FCB) scheduled a $223 million IPO on the NYSE with a market capitalization of $1.02 billion at a price range midpoint of $25.50 for Friday, August 1, 2014.

 

(8) Based in Oakbrook Terrace, IL, SIRVA (SRVA) scheduled a $186 million IPO on the Nasdaq with a market capitalization of $632 million at a price range midpoint of $16 for Friday, August 1, 2014.

SRVA is a moving/relocation company.

 

(9) Based in North Billerica, MA, Lantheus Holdings (LNTH) scheduled a $125 million IPO on the Nasdaq with a market capitalization of $370 million at a price range midpoint of $13.50 for Wednesday, July 30, 2014.

LNTH is a global leader in developing, manufacturing, selling and distributing innovative diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases.

 

(10) Based in Draper, UT, Health Equity (HQY) scheduled a $100 million IPO on the Nasdaq with a market capitalization of $546 million at a price range midpoint of $11 for Thursday, July 31, 2014.

HQY is a leader and an innovator in the high growth category of technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions.

 

(11) Based in Or Yehuda, Israel, Vascular Biogenics (VBLX) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $259 million at a price range midpoint of $14 for Thursday, July 31, 2014.

VBLX is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases.

 

(12) Based in Menlo Park, CA, Avalanche Biotechnologies (AAVL) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $292 million at a price range midpoint of $14 for Thursday, July 31, 2014.

AAVL is a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases.

 

(13) Based in Zug, Switzerland, Auris Medical Holding AG (EARS) scheduled a $76 million IPO on the Nasdaq with a market capitalization of $283 million at a price range midpoint of $11 for Friday, August 1, 2014.

EARS is a clinical-stage biopharmaceutical company focused on the development of novel products for the treatment of inner ear disorders.

 

(14) Based in Petach Tikva, Israel, Macrocure (MCUR) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $264 million at a price range midpoint of $14 for Thursday, July 31, 2014.

MCUR is a regenerative medicine company focused on developing, manufacturing and commercializing novel cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds.

 

(15) Based in Fremont, CA, Zosano Pharma (ZSAN) scheduled a $70 million IPO on the Nasdaq with a market capitalization of $134 million at a price range midpoint of $11 for $134 million for the week of July 28th.

ZSAN is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications.

 

(16) Based in South San Francisco, CA, Tobira Therapeutics (TBRA) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $143 million at a price range midpoint of $13 for Thursday, July 31, 2014.

TBRA is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV, fibrosis and inflammation.

 

(17) Based in Stamford, CT, Loxo Oncology (LOXO) scheduled a $57 million IPO on the Nasdaq with a market capitalization of $196 million at a price range midpoint of $13 for Friday, August 1, 2014.

LOXO develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations.

 

(18) Based in New Haven, CT, Marinus Pharmaceuticals (MRNS) scheduled a $52 million IPO on the Nasdaq with a market capitalization of $159 million at a price range midpoint of $13 for Thursday, July 31, 2014.

MRNS is a clinical stage biopharmaceutical company focused on developing and commercializing innovative neuropsychiatric therapeutics.

 

(19) Based in Tel Aviv, Israel, Bio Blast Pharma Ltd. (ORPN) scheduled a $40 million IPO on the Nasdaq with a market capitalization of $172 million at a price range midpoint of $172 for Friday, Aug. 1, 2014.

ORPN is a development-stage biopharmaceutical company focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.

 

(20) Based in Yonker, NY, ContraFect (CFRXU) scheduled a $20 million IPO on the Nasdaq with a market capitalization of $96 million at a price range midpoint of $5.50 for Tuesday, July 29, 2014.

CFRXU is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for SYF
Tom Loffman
19 Sep 14 19:00:35
Biggest gainers today large caps: $BABA 38.07% $VRTX 6.57% $TWTR 4.17% $WDAY 3.56% $NJ 3.21% $SYF 3.00% $SLXP 2.79% $COL 2.74% $MBLY 2.22%
FinanzLinksUSA
19 Sep 14 16:06:54
RT @IPOtweet: Alibaba scheduled to enter the Renaissance IPO ETF (IPO) $BABA $MBLY $SYF $FB $TWTR $LOCO $GPRO $IPO #IPO http://t.co/GX73Elb…
Day Trade Alerts
19 Sep 14 13:21:28
Alibaba scheduled to enter the Renaissance IPO ETF (IPO) $BABA $MBLY $SYF $FB $TWTR... http://t.co/3dUIFvvzdy via http://t.co/VS8RO1bzXJ
Renaissance Capital
19 Sep 14 13:12:08
Alibaba scheduled to enter the Renaissance IPO ETF (IPO) $BABA $MBLY $SYF $FB $TWTR $LOCO $GPRO $IPO #IPO http://t.co/GX73ElbrgI
Ariel Silahian
19 Sep 14 13:05:26
Algorithmic trading CLOSING Sep/19 $WLK(0.1 %) $RPAI(-1.8 %) $PENN(-0.2 %) $SYF(1.3 %) $RPT(-1.2 %) $PEI(4.2 %) $WLK(0.5 %) $CPN(-1.4 %)
Ariel Silahian
19 Sep 14 13:03:29
Algorithmic trading CLOSING Sep/19 $SYF(0.6 %) $CPN(-1.4 %) $WLK(0.1 %) $ROVI(0.2 %) $CLF(-0.4 %) $PEI(4.2 %) $RPAI(-1.8 %) $WLK(0.5 %)
Henrik
19 Sep 14 13:02:04
RT @sisSoftware: Algorithmic trading CLOSING Sep/19 $ROVI(0.2 %) $KMR(0.8 %) $CLF(-0.4 %) $SERV(1.9 %) $NI(-0.6 %) $TWTR(0.6 %) $SYF(0.4 %…
Ariel Silahian
19 Sep 14 13:01:02
Algorithmic trading CLOSING Sep/19 $ROVI(0.2 %) $KMR(0.8 %) $CLF(-0.4 %) $SERV(1.9 %) $NI(-0.6 %) $TWTR(0.6 %) $SYF(0.4 %) $WLK(0.1 %)
Ariel Silahian
19 Sep 14 12:44:50
Algorithmic trading CLOSING Sep/19 $SERV(2.2 %) $NS(1.5 %) $SYF(0.3 %)
E. Kobayashi-Solomon
19 Sep 14 07:45:46
Commented on: "GE: 40% Upside Potential With Limited Downside Risk" http://t.co/vqE8ZnFM23 $GE $SYF
Day Trade Alerts
19 Sep 14 06:52:09
via #AlertTrade Price Action Alert $SYF - SYNCHRONY FINANCIAL #stocks #intraday http://t.co/VS8RO1bzXJ
4-traders.com
19 Sep 14 06:05:08
NFCC® National Financial Stabilization Program Reaches One-Year Mark http://t.co/5bA3nzLIaD $BAC $SYF $WFC
Chris Wong
18 Sep 14 14:24:46
Commented on StockTwits: Also take into account the ridiculous float available, larger than even $SYF, I expect i... http://t.co/2OOLnuXKpO
Chris Wong
18 Sep 14 09:44:47
Commented on StockTwits: For some reason, I am expecting movements similar to $SYF during their IPO. sideways. http://t.co/rfinuPf3WV
US Banking News
17 Sep 14 06:35:45
Investment Analysts’ Weekly Ratings Changes for Synchrony Financial $SYF http://t.co/otrZU8DaKw
Ticker Report
17 Sep 14 06:31:19
Investment Analysts’ Weekly Ratings Changes for Synchrony Financial $SYF http://t.co/R2Q40hKqsc
KC BBQ
17 Sep 14 06:08:34
Is $civi ipo gonna pull a $syf or a $rwlk ?
E. Kobayashi-Solomon
17 Sep 14 05:45:11
Commented on: "GE: 40% Upside Potential With Limited Downside Risk" http://t.co/vqE8ZnFM23 $GE $SYF
E. Kobayashi-Solomon
15 Sep 14 11:09:26
Commented on: "GE: 40% Upside Potential With Limited Downside Risk" http://t.co/vqE8ZnFM23 $GE $SYF
CalConfidence
15 Sep 14 09:15:59
NYSE Tops 2014's Most Active Stock Exchanges Before Alibaba Debut $BABA $JD $SYF http://t.co/Uyrjl5u5Mx via @benzinga
E. Kobayashi-Solomon
14 Sep 14 05:35:37
Commented on: "GE: 40% Upside Potential With Limited Downside Risk" http://t.co/vqE8ZnFM23 $GE $SYF
Ed Rudy
13 Sep 14 05:17:02
Commented on: "General Electric Has Focus, Upside And Is Defensive (And The Divide... http://t.co/uXIoobHQ6x $GE $SYF
Company i
12 Sep 14 10:19:53
$SYF This looks like it wants to drop to 24 here, breakdown on dailys and intraday
FlashRatingsHOT
12 Sep 14 10:15:38
$SYF has 11 analyst ratings in the last 7 days. Median target: $30 (22% upside). View here: https://t.co/QlacWdXEC5
Briefing.com
12 Sep 14 09:09:15
$SYF: UBS starts at Neutral
Ed Rudy
12 Sep 14 08:17:22
Commented on: "General Electric Has Focus, Upside And Is Defensive (And The Divide... http://t.co/uXIoobHQ6x $GE $SYF
E. Kobayashi-Solomon
12 Sep 14 07:51:15
Commented on: "GE: 40% Upside Potential With Limited Downside Risk" http://t.co/vqE8ZnFM23 $GE $SYF
Biotech Investor
12 Sep 14 07:36:43
RT @jimcramer: $SYF, $V RT @TheGr8tstManEvr: @carlquintanilla @jimcramer @CNBC When was the last time a major IPO was priced fairly?
Filipek
12 Sep 14 07:20:15
2/2 $PEIX, $PANW, $RKUS, $SLXP, $S, $SYF, and $MTN./source by http://t.co/nIpeR1qqrI ; @247WallSt Thanks of lot. Best regards.
SIAnalystWire
12 Sep 14 07:09:59
UBS Starts Synchrony Financial $SYF at Neutral http://t.co/juM3MJZQKj
Hugh Jass
12 Sep 14 06:50:39
@jimcramer @carlquintanilla @CNBC Never having heard of $SYF I'll go with the 5 years ago of $V. Keep up the good work Jim!
Francisco Avila
12 Sep 14 06:48:21
RT @jimcramer: $SYF, $V RT @TheGr8tstManEvr: @carlquintanilla @jimcramer @CNBC When was the last time a major IPO was priced fairly?
Halley Suitt Tucker
12 Sep 14 06:43:14
RT @jimcramer: $SYF, $V RT @TheGr8tstManEvr: @carlquintanilla @jimcramer @CNBC When was the last time a major IPO was priced fairly?
Jim Cramer
12 Sep 14 06:42:19
$SYF, $V RT @TheGr8tstManEvr: @carlquintanilla @jimcramer @CNBC When was the last time a major IPO was priced fairly?
The Fly
12 Sep 14 03:31:42
$SYF Synchrony Financial initiated with a Neutral at UBS: Full Story http://t.co/3QVOTW9NAN
				
				
By  +Follow July 28, 2014 1:53PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.